(Q54667206)
Statements
Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer (English)
D Strumberg
B Schultheis
M E Scheulen
R A Hilger
J Krauss
N Marschner
F Lordick
F Bach
D Reuter
L Edler